background

Core lab literature references

Angiography

  1. Spitzer E, McFadden E, Vranckx P, Garcia-Garcia HM, Seltzer JH, Held C, de Vries T, Menon V, Brown KJ, Soliman OII, Onuma Y, Lopes RD, Stone GW, Cutlip DE, Serruys PW. Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials: A Guidance Document. JACC Cardiovasc Interv. 2019 May 13;12(9):805-819. doi: 10.1016/j.jcin.2018.12.031. PMID: 31072504.
  2. Masdjedi K, van Zandvoort LJC, Balbi MM, Gijsen FJH, Ligthart JMR, Rutten MCM, Lemmert ME, Wilschut J, Diletti R, De Jaegere P, Zijlstra F, Van Mieghem NM, Daemen J. Validation of 3-Dimensional Quantitative Coronary Angiography based software to calculate Fractional Flow Reserve: Fast Assessment of Stenosis severity (FAST)-study. EuroIntervention. 2019 May 14:EIJ-D-19-00466.
  3. Tovar Forero MN, van Zandvoort L, Masdjedi K, Diletti R, Wilschut J, de Jaegere PP, Zijlstra F, Van Mieghem NM, Daemen J. Serial invasive imaging follow-up of the first clinical experience with the Magmaris magnesium bioresorbable scaffold. Catheter Cardiovasc Interv. 2020 Feb;95(2):226-231.
  4. Vroegindewey MM, Schuurman AS, Kardys I, Anroedh SS, Oemrawsingh RM, Ligthart J, Garcia-Garcia HM, van Geuns RM, Regar E, Van Mieghem NM, Serruys PW, Boersma E, Akkerhuis M. SYNTAX score in relation to intravascular ultrasound and near-infrared spectroscopy for the assessment of atherosclerotic burden in patients with coronary artery disease. 2019 Jan 20;14(13):1408-1415.
  5. van Gils L, Wöhrle J, Hildick-Smith D, Bleiziffer S, Blackman DJ, Abdel-Wahab M, Gerckens U, Brecker S, Bapat V, Modine T, Soliman OI, Nersesov A, Allocco D, Falk V, Van Mieghem NM. Importance of Contrast Aortography With Lotus Transcatheter Aortic Valve Replacement: A Post Hoc Analysis From the RESPOND Post-Market Study. JACC Cardiovasc Interv. 2018 Jan 22;11(2):119-128.
  6. Biesbroek PS, Hirsch A, Zweerink A, van de Ven PM, Beek AM, Groenink M, Windhausen F, Planken RN, van Rossum AC, Nijveldt R. Additional diagnostic value of CMR to the European Society of Cardiology (ESC) position statement criteria in a large clinical population of patients with suspected myocarditis. Eur Heart J Cardiovasc Imaging. 2018 Dec 1;19(12):1397-1407.
  7. Schuurman AS, Vroegindewey M, Kardys I, Oemrawsingh RM, Cheng JM, de Boer S, Garcia-Garcia HM, van Geuns RJ, Regar ES, Daemen J, van Mieghem NM, Serruys PW, Boersma E, Akkerhuis KM. Near-infrared spectroscopy-derived lipid core burden index predicts adverse cardiovascular outcome in patients with coronary artery disease during long-term follow-up. Eur Heart J. 2018 Jan 21;39(4):295-302.
  8. van Bommel RJ, Lemmert ME, van Mieghem NM, van Geuns RJ, van Domburg RT, Daemen J. Occurrence and predictors of acute stent recoil-A comparison between the xience prime cobalt chromium stent and the promus premier platinum chromium stent. Catheter Cardiovasc Interv. 2018 Feb 15;91(3):E21-E28.
  9. Spitzer E, de Vries T, Cavalcante R, Tuinman M, Rademaker-Havinga T, Alkema M, Morel MA, Soliman OI, Onuma Y, van Es GA, Tijssen JGP, McFadden E, Serruys PW. Detecting Periprocedural Myocardial Infarction in Contemporary Percutaneous Coronary Intervention Trials. JACC Cardiovasc Interv. 2017 Apr 10;10(7):658-666.
  10. De Paolis M, Felix C, van Ditzhuijzen N, Fam JM, Karanasos A, de Boer S, van Mieghem NM, Daemen J, Costa F, Bergoli LC, Ligthart JM, Regar E, de Jaegere PP, Zijlstra F, van Geuns RJ, Diletti R. Everolimus-eluting bioresorbable vascular scaffolds implanted in coronary bifurcation lesions: Impact of polymeric wide struts on side-branch impairment. Int J Cardiol. 2016 Oct 15;221:656-64.
  11. Abdelghani M, Tateishi H, Spitzer E, Tijssen JG, de Winter RJ, Soliman OI, Hahn RT, Serruys PW. Echocardiographic and angiographic assessment of paravalvular regurgitation after TAVI: optimizing inter-technique reproducibility. Eur Heart J Cardiovasc Imaging. 2016 Aug;17(8):852-60.
  12. Tateishi H, Campos CM, Abdelghani M, Leite RS, Mangione JA, Bary L, Soliman OI, Spitzer E, Perin MA, Onuma Y, Serruys PW, Lemos PA, Brito FS Jr. Video densitometric assessment of aortic regurgitation after transcatheter aortic valve implantation: results from the Brazilian TAVI registry. EuroIntervention. 2016 Mar;11(12):1409-18.
  13. Lemos PA, Saia F, Ligthart JM, Arampatzis CA, Sianos G, Tanabe K, Hoye A, Degertekin M, Daemen J, McFadden E, Hofma S, Smits PC, de Feyter P, van der Giessen WJ, van Domburg RT, Serruys PW. Coronary restenosis after sirolimus eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases. Circulation. 2003 Jul 22;108(3):257-60.


Intra Coronary Imaging

  1. van Zandvoort LJC, Masdjedi K, Neleman T, Tovar Forero MN, Wilschut J, den Dekker W, de Jaegere PPT, Diletti R, Zijlstra F, Van Mieghem NM, Daemen J. Impact of intravascular ultrasound findings in patients with a post PCI fractional flow reserve ≤0.85 on 2 year clinical outcome. Int J Cardiol. 2020 May 18:S0167-5273(20)32272-5.
  2. Cecchetti L, Wang T, Hoogendoorn A, Witberg KT, Ligthart JMR, Daemen J, van Beusekom HMM, Pfeiffer T, Huber RA, Wentzel JJ, van der Steen AFW, van Soest G. In-vitro and in-vivo imaging of coronary artery stents with Heartbeat OCT. Int J Cardiovasc Imaging. 2020 Jun;36(6):1021-1029.
  3. van Zandvoort LJC, Tomaniak M, Tovar Forero MN, Masdjedi K, Visseren L, Witberg K, Ligthart J, Kardys I, Lemmert ME, Diletti R, Wilschut J, de Jaegere P, Zijlstra F, Van Mieghem NM, Daemen J. Predictors for Clinical Outcome of Untreated Stent Edge Dissections as Detected by Optical Coherence Tomography. Circ Cardiovasc Interv. 2020 Mar;13(3):e008685.
  4. Wang T, Pfeiffer T, Daemen J, Mastik F, Wieser W, van der Steen AFW, Huber R, van Soest G. Simultaneous Morphological and Flow Imaging Enabled by Megahertz Intravascular Doppler Optical Coherence Tomography. IEEE Trans Med Imaging. 2020 May;39(5):1535-1544. 31725370.
  5. Otsuka K, Villiger M, Karanasos A, van Zandvoort LJC, Doradla P, Ren J, Lippok N, Daemen J, Diletti R, van Geuns RJ, Zijlstra F, van Soest G, Dijkstra J, Nadkarni SK, Regar E, Bouma BE. Intravascular Polarimetry in Patients With Coronary Artery Disease. JACC Cardiovasc Imaging. 2020 Mar;13(3):790-801.
  6. van Zandvoort LJC, Masdjedi K, Tovar Forero MN, Lenzen MJ, Ligthart J, Diletti R, Lemmert ME, Wilschut J, de Jaegere PPT, Zijlstra F, van Mieghem NM, Daemen J. Fractional flow reserve guided percutaneous coronary intervention optimization directed by high-definition intravascular ultrasound versus standard of care: Rationale and study design of the prospective randomized FFR-REACT trial. Am Heart J. 2019 Jul;213:66-72.
  7. Tovar Forero MN, van Zandvoort L, Masdjedi K, Diletti R, Wilschut J, de Jaegere PP, Zijlstra F, Van Mieghem NM, Daemen J. Serial invasive imaging follow-up of the first clinical experience with the Magmaris magnesium bioresorbable scaffold. Catheter Cardiovasc Interv. 2020 Feb;95(2):226-231.
  8. Doradla P, Otsuka K, Nadkarni A, Villiger M, Karanasos A, Zandvoort LJCV, Dijkstra J, Zijlstra F, Soest GV, Daemen J, Regar E, Bouma BE, Nadkarni SK. Biomechanical Stress Profiling of Coronary Atherosclerosis: Identifying a Multifactorial Metric to Evaluate Plaque Rupture Risk. JACC Cardiovasc Imaging. 2020 Mar;13(3):804-816.
  9. Simonsen JK, Holck EN, Carrié D, Frey N, Lutz M, Weber-Albers J, Dudek D, Chevalier B, Daemen J, Dijkstra J, Fox Maule C, Neghabat O, Lassen JF, Anderson J, Christiansen EH, Abizaid A, Holm NR. Mechanical performance and healing patterns of the novel sirolimus-eluting bioresorbable Fantom scaffold: 6-month and 9-month follow-up by optical coherence tomography in the FANTOM II study. Open Heart. 2019 Feb 28;6(1):e000941.
  10. van Zandvoort LJC, Masdjedi K, Witberg K, Ligthart J, Tovar Forero MN, Diletti R, Lemmert ME, Wilschut J, de Jaegere PPT, Boersma E, Zijlstra F, Van Mieghem NM, Daemen J. Explanation of Postprocedural Fractional Flow Reserve Below 0.85. Circ Cardiovasc Interv. 2019 Feb;12(2):e007030.
  11. Schuurman AS, Vroegindewey MM, Kardys I, Oemrawsingh RM, Garcia-Garcia HM, van Geuns RJ, Regar E, Van Mieghem NM, Ligthart J, Serruys PW, Boersma E, Akkerhuis KM. Prognostic Value of Intravascular Ultrasound in Patients With Coronary Artery Disease. J Am Coll Cardiol. 2018 Oct 23;72(17):2003-2011.
  12. van Zandvoort LJC, Tovar Forero MN, Masdjedi K, Lemmert ME, Diletti R, Wilschut J, de Jaegere P, Zijlstra F, Van Mieghem NM, Daemen J. References for left main stem dimensions: A cross sectional intravascular ultrasound analysis. Catheter Cardiovasc Interv. 2019 Feb 1;93(2):233-238.
  13. van Zandvoort LJC, Dudek D, Weber-Albers J, Abizaid A, Christiansen EH, Muller DWM, Kochman J, Kołtowski Ł, Lassen JF, Wojdyla R, Wykrzykowska JJ, Onuma Y, Daemen J. Intravascular ultrasound findings of the Fantom sirolimus-eluting bioresorbable scaffold at six- and nine-month follow-up: the FANTOM II study. EuroIntervention. 2018 Dec 7;14(11):e1215-e1223.
  14. Anroedh SS, Akkerhuis KM, Oemrawsingh RM, Garcia-Garcia HM, Brankovic M, Regar E, van Geuns RJ, Serruys PW, Daemen J, van Mieghem NM, Boersma E, Kardys I. Associations of 26 Circulating Inflammatory and Renal Biomarkers with Near-Infrared Spectroscopy and Long-term Cardiovascular Outcome in Patients Undergoing Coronary Angiography (ATHEROREMO-NIRS Substudy). Curr Atheroscler Rep. 2018 Sep 14;20(10):52.
  15. Villiger M, Otsuka K, Karanasos A, Doradla P, Ren J, Lippok N, Shishkov M, Daemen J, Diletti R, van Geuns RJ, Zijlstra F, Dijkstra J, van Soest G, Regar E, Nadkarni SK, Bouma BE. Repeatability Assessment of Intravascular Polarimetry in Patients. IEEE Trans Med Imaging. 2018 Jul;37(7):1618-1625.
  16. Vroegindewey MM, Schuurman AS, Kardys I, Anroedh SS, Oemrawsingh RM, Ligthart J, Garcia-Garcia HM, van Geuns RM, Regar E, Van Mieghem NM, Serruys PW, Boersma E, Akkerhuis M. SYNTAX score in relation to intravascular ultrasound and near-infrared spectroscopy for the assessment of atherosclerotic burden in patients with coronary artery disease. EuroIntervention. 2019 Jan 20;14(13):1408-1415.
  17. Villiger M, Otsuka K, Karanasos A, Doradla P, Ren J, Lippok N, Shishkov M, Daemen J, Diletti R, van Geuns RJ, Zijlstra F, van Soest G, Libby P, Regar E, Nadkarni SK, Bouma BE. Coronary Plaque Microstructure and Composition Modify Optical Polarization: A New Endogenous Contrast Mechanism for Optical Frequency Domain Imaging. JACC Cardiovasc Imaging. 2018 Nov;11(11):1666-1676.
  18. Ali ZA, Brinton TJ, Hill JM, Maehara A, Matsumura M, Karimi Galougahi K, Illindala U, Götberg M, Whitbourn R, Van Mieghem N, Meredith IT, Di Mario C, Fajadet J. Optical Coherence Tomography Characterization of Coronary Lithoplasty for Treatment of Calcified Lesions: First Description. JACC Cardiovasc Imaging. 2017 Aug;10(8):897-906.
  19. Schuurman AS, Vroegindewey M, Kardys I, Oemrawsingh RM, Cheng JM, de Boer S, Garcia-Garcia HM, van Geuns RJ, Regar ES, Daemen J, van Mieghem NM, Serruys PW, Boersma E, Akkerhuis KM. Near-infrared spectroscopy-derived lipid core burden index predicts adverse cardiovascular outcome in patients with coronary artery disease during long-term follow-up. Eur Heart J. 2018 Jan 21;39(4):295-302.
  20. Lemmert ME, Oldroyd K, Barragan P, Lesiak M, Byrne RA, Merkulov E, Daemen J, Onuma Y, Witberg K, van Geuns RJ. Reduced duration of dual antiplatelet therapy using an improved drug-eluting stent for percutaneous coronary intervention of the left main artery in a real-world, all-comer population: Rationale and study design of the prospective randomized multicenter IDEAL-LM trial. Am Heart J. 2017 May;187:104-111.
  21. Ming Fam J, van Der Sijde JN, Karanasos A, Felix C, Diletti R, van Mieghem N, de Jaegere P, Zijlstra F, Jan van Geuns R, Regar E. Comparison of acute expansion of bioresorbable vascular scaffolds versus metallic drug-eluting stents in different degrees of calcification: An Optical Coherence Tomography Study. Catheter Cardiovasc Interv. 2017 Apr;89(5):798-810.
  22. Oemrawsingh RM, Garcia-Garcia HM, van Geuns RJ, Lenzen MJ, Simsek C, de Boer SP, Van Mieghem NM, Regar E, de Jaegere PP, Akkerhuis KM, Ligthart JM, Zijlstra F, Serruys PW, Boersma E. Integrated Biomarker and Imaging Study 3 (IBIS-3) to assess the ability of rosuvastatin to decrease necrotic core in coronary arteries. EuroIntervention. 2016 Aug 20;12(6):734-9.
  23. De Paolis M, Felix C, van Ditzhuijzen N, Fam JM, Karanasos A, de Boer S, van Mieghem NM, Daemen J, Costa F, Bergoli LC, Ligthart JM, Regar E, de Jaegere PP, Zijlstra F, van Geuns RJ, Diletti R. Everolimus-eluting bioresorbable vascular scaffolds implanted in coronary bifurcation lesions: Impact of polymeric wide struts on side-branch impairment. Int J Cardiol. 2016 Oct 15;221:656-64.
  24. Diletti R, van der Sijde J, Karanasos A, Fam JM, Felix C, van Mieghem NM, Regar E, Rapoza R, Zijlstra F, van Geuns RJ. Differential thrombotic prolapse burden in either bioresorbable vascular scaffolds or metallic stents implanted during acute myocardial infarction: The snowshoe effect: Insights from the maximal footprint analysis. Int J Cardiol. 2016 Oct 1;220:802-8.
  25. van der Sijde JN, Karanasos A, van Ditzhuijzen NS, Okamura T, van Geuns RJ, Valgimigli M, Ligthart JM, Witberg KT, Wemelsfelder S, Fam JM, Zhang B, Diletti R, de Jaegere PP, van Mieghem NM, van Soest G, Zijlstra F, van Domburg RT, Regar E. Safety of optical coherence tomography in daily practice: a comparison with intravascular ultrasound. Eur Heart J Cardiovasc Imaging. 2017 Apr 1;18(4):467-474.
  26. Karanasos A, Van Mieghem N, van Ditzhuijzen N, Felix C, Daemen J, Autar A, Onuma Y, Kurata M, Diletti R, Valgimigli M, Kauer F, van Beusekom H, de Jaegere P, Zijlstra F, van Geuns RJ, Regar E. Angiographic and optical coherence tomography insights into bioresorbable scaffold thrombosis: single-center experience. Circ Cardiovasc Interv. 2015 May;8(5):e002369.
  27. Karanasos A, Muramatsu T, Diletti R, Nauta S, Onuma Y, Lenzen M, Nakatani S, Van Mieghem NM, Schultz C, De Jaegere PP, Serruys PW, Zijlstra F, Regar E, van Geuns RJ. Early and late optical coherence tomography findings following everolimus-eluting bioresorbable vascular scaffold implantation in myocardial infarction: a preliminary report. Hellenic J Cardiol. 2015 Mar-Apr;56(2):125-35.
  28. Karanasos A, Simsek C, Gnanadesigan M, van Ditzhuijzen NS, Freire R, Dijkstra J, Tu S, Van Mieghem N, van Soest G, de Jaegere P, Serruys PW, Zijlstra F, van Geuns RJ, Regar E. OCT assessment of the long-term vascular healing response 5 years after everolimus-eluting bioresorbable vascular scaffold. J Am Coll Cardiol. 2014 Dec 9;64(22):2343-56.
  29. Karanasos A, Tu S, van Ditzhuijzen NS, Ligthart JM, Witberg K, Van Mieghem N, van Geuns RJ, de Jaegere P, Zijlstra F, Reiber JH, Regar E. A novel method to assess coronary artery bifurcations by OCT: cut-plane analysis for side-branch ostial assessment from a main-vessel pullback. Eur Heart J Cardiovasc Imaging. 2015 Feb;16(2):177-89.
  30. van Mieghem N, Wilschut JJ, Ligthart J, Witberg K, van Geuns RJ, Regar E. Modified T-technique with bioresorbable scaffolds ensures complete carina coverage: an optical coherence tomography study. JACC Cardiovasc Interv. 2014 Aug;7(8):e109-10.
  31. Brugaletta S, Garcia-Garcia HM, Serruys PW, de Boer S, Ligthart J, Gomez-Lara J, Witberg K, Diletti R, Wykrzykowska J, van Geuns RJ, Schultz C, Regar E, Duckers HJ, van Mieghem N, de Jaegere P, Madden SP, Muller JE, van der Steen AF, van der Giessen WJ, Boersma E. NIRS and IVUS for characterization of atherosclerosis in patients undergoing coronary angiography. JACC Cardiovasc Imaging. 2011 Jun;4(6):647-55.


Magnetic Resonance Imaging

  1. van den Hoven AT, Yilmazer S, Chelu RG, van Grootel RWJ, Minderhoud SCS, Bons LR, van Berendoncks AM, Duijnhouwer AL, Siebelink HJ, van den Bosch AE, Budde RPJ, Roos-Hesselink JW, Hirsch A. Left ventricular global longitudinal strain in bicupsid aortic valve patients: head-to-head comparison between computed tomography, 4D flow cardiovascular magnetic resonance and speckle-tracking echocardiography. Int J Cardiovasc Imaging. 2020 May 25.
  2. van Waning JI, Caliskan K, Chelu RG, van der Velde N, Pezzato A, Michels M, van Slegtenhorst MA, Boersma E, Nieman K, Majoor-Krakauer D, Hirsch A. Diagnostic CMR Imaging Criteria in Noncompaction Cardiomyopathy and the Yield of Genetic Testing. Can J Cardiol. 2020 May 20:S0828-282X(20)30500-6.
  3. Elias J, van Dongen IM, Hoebers LP, Ouweneel DM, Claessen BEPM, Råmunddal T, Laanmets P, Eriksen E, Piek JJ, van der Schaaf RJ, Ioanes D, Nijveldt R, Tijssen JG, Henriques JPS, Hirsch A; EXPLORE Recovery and prognostic value of myocardial strain in ST-segment elevation myocardial infarction patients with a concurrent chronic total occlusion. Eur Radiol. 2020 Jan;30(1):600-608.
  4. Stam K, Cai Z, van der Velde N, van Duin R, Lam E, van der Velden J, Hirsch A, Duncker DJ, Merkus D. Cardiac remodelling in a swine model of chronic thromboembolic pulmonary hypertension: comparison of right vs. left ventricle. J Physiol. 2019 Sep;597(17):4465-4480.
  5. Stam K, Chelu RG, van der Velde N, van Duin R, Wielopolski P, Nieman K, Merkus D, Hirsch A. Validation of 4D flow CMR against simultaneous invasive hemodynamic measurements: a swine study. Int J Cardiovasc Imaging. 2019 Jun;35(6):1111-1118.
  6. van Leeuwen MAH, van der Hoeven NW, Janssens GN, Everaars H, Nap A, Lemkes JS, de Waard GA, van de Ven PM, van Rossum AC, Ten Cate TJF, Piek JJ, von Birgelen C, Escaned J, Valgimigli M, Diletti R, Riksen NP, van Mieghem NM, Nijveldt R, van Royen N. Evaluation of Microvascular Injury in Revascularized Patients With ST-Segment-Elevation Myocardial Infarction Treated With Ticagrelor Versus Prasugrel. 2019 Jan 29;139(5):636-646.
  7. Velu JF, Hirsch A, Boekholdt SM, Koch KT, Marije Vis M, Nils Planken R, Piek JJ, Baan J Jr, Bouma BJ. Myocardial fibrosis predicts adverse outcome after MitraClip implantation. Catheter Cardiovasc Interv. 2019 May 1;93(6):1146-1149.
  8. Ter Horst EN, Krijnen PAJ, Hakimzadeh N, Robbers LFHJ, Hirsch A, Nijveldt R, Lommerse I, Fontijn RD, Meinster E, Delewi R, van Royen N, Zijlstra F, van Rossum AC, van der Schoot CE, van der Pouw Kraan TCTM, Horrevoets AJ, van der Laan AM, Niessen HWM, Piek JJ. Elevated monocyte-specific type I interferon signalling correlates positively with cardiac healing in myocardial infarct patients but interferon alpha application deteriorates myocardial healing in rats. Basic Res Cardiol. 2018 Nov 12;114(1):1.
  9. Bons LR, Duijnhouwer AL, Boccalini S, van den Hoven AT, van der Vlugt MJ, Chelu RG, McGhie JS, Kardys I, van den Bosch AE, Siebelink HJ, Nieman K, Hirsch A, Broberg CS, Budde RPJ, Roos-Hesselink JW. Intermodality variation of aortic dimensions: How, where and when to measure the ascending aorta. Int J Cardiol. 2019 Feb 1;276:230-235.
  10. Feyz L, El Faquir N, Lemmert ME, Misier KR, van Zandvoort LJC, Budde RPJ, Boersma E, Zijlstra F, de Jaegere P, Van Mieghem NM, Daemen J. Prevalence and consequences of noncardiac incidental findings on preprocedural imaging in the workup for transcatheter aortic valve implantation, renal sympathetic denervation, or MitraClip implantation. Am Heart J. 2018 Oct;204:83-91.
  11. Everaars H, Robbers LFHJ, Götte M, Croisille P, Hirsch A, Teunissen PFA, van de Ven PM, van Royen N, Zijlstra F, Piek JJ, van Rossum AC, Nijveldt R. Strain analysis is superior to wall thickening in discriminating between infarcted myocardium with and without microvascular obstruction. Eur Radiol. 2018 Dec;28(12):5171-5181.
  12. Caplice NM, DeVoe MC, Choi J, Dahly D, Murphy T, Spitzer E, Van Geuns R, Maher MM, Tuite D, Kerins DM, Ali MT, Kalyar I, Fahy EF, Khider W, Kelly P, Kearney PP, Curtin RJ, O'Shea C, Vaughan CJ, Eustace JA, McFadden EP. Randomized placebo controlled trial evaluating the safety and efficacy of single low-dose intracoronary insulin-like growth factor following percutaneous coronary intervention in acute myocardial infarction (RESUS-AMI). Am Heart J. 2018 Jun;200:110-117. 29898838.
  13. Biesbroek PS, Hirsch A, Zweerink A, van de Ven PM, Beek AM, Groenink M, Windhausen F, Planken RN, van Rossum AC, Nijveldt R. Additional diagnostic value of CMR to the European Society of Cardiology (ESC) position statement criteria in a large clinical population of patients with suspected myocarditis. Eur Heart J Cardiovasc Imaging. 2018 Dec 1;19(12):1397-1407.
  14. Hassell ME, Vlastra W, Robbers L, Hirsch A, Nijveldt R, Tijssen JG, van Rossum AC, Zijlstra F, Piek JJ, Delewi R. Long-term left ventricular remodeling after revascularisation for ST-segment elevation myocardial infarction as assessed by cardiac magnetic resonance imaging. Open Heart. 2017 May 22;4(1):e000569.
  15. Elias J, van Dongen IM, Hoebers LP, Ouweneel DM, Claessen BEPM, Råmunddal T, Laanmets P, Eriksen E, van der Schaaf RJ, Ioanes D, Nijveldt R, Tijssen JG, Hirsch A, Henriques JPS; EXPLORE investigators. Improved recovery of regional left ventricular function after PCI of chronic total occlusion in STEMI patients: a cardiovascular magnetic resonance study of the randomized controlled EXPLORE trial. J Cardiovasc Magn Reson. 2017 Jul 19;19(1):53.
  16. van Zandvoort L, van Kranenburg M, Karanasos A, Van Mieghem N, Ouhlous M, van Geuns RJ, van Domburg R, Daemen J. Serial quantitative magnetic resonance angiography follow-up of renal artery dimensions following treatment by four different renal denervation systems. EuroIntervention. 2017 Apr 7;12(18):e2271-e2277.
  17. Lemkes J, Nijveldt R, Beek AM, Knaapen P, Hirsch A, Meijers J, Allaart CP, van Rossum A, van Royen N. Evaluating the optimal timing of revascularisation in patients with transient ST-segment elevation myocardial infarction: rationale and design of the TRANSIENT Trial. J Cardiovasc Transl Res. 2014 Aug;7(6):590-6.
  18. Robbers LF, Nijveldt R, Beek AM, Hirsch A, van der Laan AM, Delewi R, van der Vleuten PA, Tio RA, Tijssen JG, Hofman MB, Piek JJ, Zijlstra F, van Rossum AC; HEBE Investigators. Cell therapy in reperfused acute myocardial infarction does not improve the recovery of perfusion in the infarcted myocardium: a cardiac MR imaging study. Radiology. 2014 Jul;272(1):113-22.
  19. Robbers LF, Delewi R, Nijveldt R, Hirsch A, Beek AM, Kemme MJ, van Beurden Y, van der Laan AM, van der Vleuten PA, Tio RA, Zijlstra F, Piek JJ, van Rossum AC. Myocardial infarct heterogeneity assessment by late gadolinium enhancement cardiovascular magnetic resonance imaging shows predictive value for ventricular arrhythmia development after acute myocardial infarction. Eur Heart J Cardiovasc Imaging. 2013 Dec;14(12):1150-8.
  20. Delewi R, Ijff G, van de Hoef TP, Hirsch A, Robbers LF, Nijveldt R, van der Laan AM, van der Vleuten PA, Lucas C, Tijssen JG, van Rossum AC, Zijlstra F, Piek JJ. Pathological Q waves in myocardial infarction in patients treated by primary PCI. JACC Cardiovasc Imaging. 2013 Mar;6(3):324-31.
  21. Delewi R, Nijveldt R, Hirsch A, Marcu CB, Robbers L, Hassell ME, de Bruin RH, Vleugels J, van der Laan AM, Bouma BJ, Tio RA, Tijssen JG, van Rossum AC, Zijlstra F, Piek JJ. Left ventricular thrombus formation after acute myocardial infarction as assessed by cardiovascular magnetic resonance imaging. Eur J Radiol. 2012 Dec;81(12):3900-4.
  22. van der Laan AM, Hirsch A, Robbers LF, Nijveldt R, Lommerse I, Delewi R, van der Vleuten PA, Biemond BJ, Zwaginga JJ, van der Giessen WJ, Zijlstra F, van Rossum AC, Voermans C, van der Schoot CE, Piek JJ. A proinflammatory monocyte response is associated with myocardial injury and impaired functional outcome in patients with ST-segment elevation myocardial infarction: monocytes and myocardial infarction. Am Heart J. 2012 Jan;163(1):57-65.e2.
  23. Hirsch A, Nijveldt R, van der Vleuten PA, Tijssen JG, van der Giessen WJ, Tio RA, Waltenberger J, ten Berg JM, Doevendans PA, Aengevaeren WR, Zwaginga JJ, Biemond BJ, van Rossum AC, Piek JJ, Zijlstra F; HEBE Investigators. Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial. Eur Heart J. 2011 Jul;32(14):1736-47.
  24. Haeck JD, Verouden NJ, Kuijt WJ, Koch KT, Majidi M, Hirsch A, Tijssen JG, Krucoff MW, De Winter RJ. Impact of early, late, and no ST-segment resolution measured by continuous ST Holter monitoring on left ventricular ejection fraction and infarct size as determined by cardiovascular magnetic resonance imaging. J Electrocardiol. 2011 Jan-Feb;44(1):36-41.
  25. Nijveldt R, van der Vleuten PA, Hirsch A, Beek AM, Tio RA, Tijssen JG, Piek JJ, van Rossum AC, Zijlstra F. Early electrocardiographic findings and MR imaging-verified microvascular injury and myocardial infarct size. JACC Cardiovasc Imaging. 2009 Oct;2(10):1187-94.
  26. Nijveldt R, Beek AM, Hirsch A, Stoel MG, Hofman MB, Umans VA, Algra PR, Twisk JW, van Rossum AC. Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury. J Am Coll Cardiol. 2008 Jul 15;52(3):181-9.
  27. Hirsch A, Nijveldt R, Haeck JD, Beek AM, Koch KT, Henriques JP, van der Schaaf RJ, Vis MM, Baan J Jr, de Winter RJ, Tijssen JG, van Rossum AC, Piek JJ. Relation between the assessment of microvascular injury by cardiovascular magnetic resonance and coronary Doppler flow velocity measurements in patients with acute anterior wall myocardial infarction. J Am Coll Cardiol. 2008 Jun 10;51(23):2230-8.
  28. Hirsch A, Nijveldt R, van der Vleuten PA, Tio RA, van der Giessen WJ, Marques KM, Doevendans PA, Waltenberger J, Ten Berg JM, Aengevaeren WR, Biemond BJ, Tijssen JG, van Rossum AC, Piek JJ, Zijlstra F. Intracoronary infusion of autologous mononuclear bone marrow cells in patients with acute myocardial infarction treated with primary PCI: Pilot study of the multicenter HEBE trial. Catheter Cardiovasc Interv. 2008 Feb 15;71(3):273-81.
  29. Nijveldt R, Hirsch A, Hofman MB, Beek AM, Spijkerboer AM, Piek JJ, van Rossum AC. 3.0 T cardiovascular magnetic resonance in patients treated with coronary stenting for myocardial infarction: evaluation of short term safety and image quality. Int J Cardiovasc Imaging. 2008 Mar;24(3):283-91.
  30. Tulevski II, van der Wall EE, Groenink M, Dodge-Khatami A, Hirsch A, Stoker J, Mulder BJ. Usefulness of magnetic resonance imaging dobutamine stress in asymptomatic and minimally symptomatic patients with decreased cardiac reserve from congenital heart disease (complete and corrected transposition of the great arteries and subpulmonic obstruction). Am J Cardiol. 2002 May 1;89(9):1077-81.


Electrocardiography

  1. Yap SC, Roos-Hesselink JW, Hoendermis ES, Budts W, Vliegen HW, Mulder BJ, van Dijk AP, Schalij MJ, Drenthen W. Outcome of implantable cardioverter defibrillators in adults with congenital heart disease: a multi-centre study. Eur Heart J. 2007 Aug;28(15):1854-61.
  2. Yap SC, Harris L, Chauhan VS, Oechslin EN, Silversides CK. Identifying high risk in adults with congenital heart disease and atrial arrhythmias. Am J Cardiol. 2011 Sep 1;108(5):723-8.
  3. Opić P, van Kranenburg M, Yap SC, van Dijk AP, Budts W, Vliegen HW, van Erven L, Can A, Sahin G, Theuns DA, Witsenburg M, Roos-Hesselink JW. Complications of pacemaker therapy in adults with congenital heart disease: a multicenter study. Int J Cardiol. 2013 Oct 9;168(4):3212-6.
  4. Opic P, Yap SC, Van Kranenburg M, Van Dijk AP, Budts W, Vliegen HW, Van Erven L, Can A, Sahin G, De Groot NM, Witsenburg M, Roos-Hesselink JW. Atrial-based pacing has no benefit over ventricular pacing in preventing atrial arrhythmias in adults with congenital heart disease. 2013 Dec;15(12):1757-62.
  5. Yap SC, Schaer BA, Bhagwandien RE, Kühne M, Dabiri Abkenari L, Osswald S, Szili-Torok T, Sticherling C, Theuns DA. Evaluation of the need of elective implantable cardioverter-defibrillator generator replacement in primary prevention patients without prior appropriate ICD therapy. Heart. 2014 Aug;100(15):1188-92.
  6. Hendriks AA, Khan M, Geller L, Kardos A, de Vries LJ, Yap SC, Wijchers SA, Theuns DA, Szili-Torok T. Ventricular tachycardia in ischemic cardiomyopathy; a combined endo-epicardial ablation as the first procedure versus a stepwise approach (EPILOGUE) - study protocol for a randomized controlled trial. 2015 Oct 29;16:487.
  7. von Gunten S, Schaer BA, Yap SC, Szili-Torok T, Kühne M, Sticherling C, Osswald S, Theuns DA. Longevity of implantable cardioverter defibrillators: a comparison among manufacturers and over time. Europace. 2016 May;18(5):710-7.
  8. van Velzen HG, Theuns DA, Yap SC, Michels M, Schinkel AF. Incidence of Device-Detected Atrial Fibrillation and Long-Term Outcomes in Patients With Hypertrophic Cardiomyopathy. Am J Cardiol. 2017 Jan 1;119(1):100-105.
  9. Kis Z, Theuns DA, Bhagwandien R, Wijchers S, Yap SC, Szili-Torok T. Type and rate of atrial fibrillation termination due to rotational activity ablation combined with pulmonary vein isolation. J Cardiovasc Electrophysiol. 2017 Aug;28(8):862-869.
  10. Yap SC, Bhagwandien RE, Szili-Torok T, Theuns DAMJ. Air entrapment causing early inappropriate shocks in a patient with a subcutaneous cardioverter- defibrillator. HeartRhythm Case Rep. 2015 Feb 25;1(3):156-158.
  11. Yap SC, Sakhi R, Theuns DAMJ, Yasar YE, Bhagwandien RE, Diletti R, Zijlstra F, Szili-Torok T. Increased risk of ventricular arrhythmias in survivors of out- of-hospital cardiac arrest with chronic total coronary occlusion. Heart Rhythm. 2018 Jan;15(1):124-129.
  12. Sakhi R, Theuns DAMJ, Bhagwandien RE, Michels M, Schinkel AFL, Szili-Torok T, Zijlstra F, Roos-Hesselink JW, Yap SC. Value of implantable loop recorders in patients with structural or electrical heart disease. J Interv Card Electrophysiol. 2018 Jul;52(2):203-208.
  13. Sakhi R, Yap SC, Michels M, Schinkel AFL, Kauling RM, Roos-Hesselink JW, Theuns DAMJ. Evaluation of a novel automatic screening tool for determining eligibility for a subcutaneous implantable cardioverter-defibrillator. Int J Cardiol. 2018 Dec 1;272:97-101.
  14. Sakhi R, Theuns DAMJ, Cosgun D, Michels M, Schinkel AFL, Kauling RM, Roos-Hesselink JW, Yap SC. Usefulness of a standard 12-lead electrocardiogram to predict the eligibility for a subcutaneous defibrillator. J Electrocardiol. 2019 Jul-Aug;55:123-127.
  15. Mutluer FO, Canpolat U, Yap SC. Premature ventricular contraction-induced cardiomyopathy entails more than only systolic left ventricular dysfunction. Heart. 2020 Jan;106(2):164.
  16. Yalcin YC, Kooij C, Theuns DAMJ, Constantinescu AA, Brugts JJ, Manintveld OC, Yap SC, Szili-Torok T, Bogers AJJC, Caliskan K. Emerging electromagnetic interferences between implantable cardioverter-defibrillators and left ventricular assist devices. 2020 Apr 1;22(4):584-587.
  17. Hoogendijk MG, Géczy T, Yap SC, Szili-Torok T. Pathophysiological Mechanisms of Premature Ventricular Complexes. Front Physiol. 2020 May 13;11:406.
  18. Bhagwandien RE, Kik C, Yap SC, Szili-Torok T. Substernal ICD lead implantation in a patient not suitable for subcutaneous ICD implantation without venous access due to superior vena cava syndrome. HeartRhythm Case Rep. 2016 Sep 28;3(1):97-99.


Echocardiography

  1. Ren B, de Groot-de Laat LE, Geleijnse ML. Left atrial function in patients with mitral valve regurgitation. Am J Physiol Heart Circ Physiol. 2014 Nov 15;307(10):H1430-7. 25217651.
  2. Ren B, Vletter WB, McGhie J, Soliman OI, Geleijnse ML. Single-beat real-time three-dimensional echocardiographic automated contour detection for quantification of left ventricular volumes and systolic function. Int J Cardiovasc Imaging. 2014 Feb;30(2):287-94.
  3. Ren B, de Groot-de Laat LE, McGhie J, Vletter WB, Ten Cate FJ, Geleijnse ML. Geometric errors of the pulsed-wave Doppler flow method in quantifying degenerative mitral valve regurgitation: a three-dimensional echocardiography study. J Am Soc Echocardiogr. 2013 Mar;26(3):261-9.
  4. Ren B, Mulder HW, Haak A, van Stralen M, Szili-Torok T, Pluim JP, Geleijnse ML, Bosch JG. A transoesophageal echocardiographic image acquisition protocol for wide-view fusion of three-dimensional datasets to support atrial fibrillation catheter ablation. J Interv Card Electrophysiol. 2013 Jun;37(1):21-6.
  5. Ren B, Tang H, Kang Y. Visualisation of the aortic annulus using the real-time three-dimensional transesophageal echocardiography. Heart. 2011 May;97(10):862-3.
  6. Spitzer E, Ren B, Kroon H, van Gils L, Manintveld O, Daemen J, Zijlstra F, de Jaegere PP, Geleijnse ML, Van Mieghem NM. Moderate Aortic Stenosis and Reduced Left Ventricular Ejection Fraction: Current Evidence and Challenges Ahead. Front Cardiovasc Med. 2018 Aug 17;5:111.
  7. Mulder HW, van Stralen M, Ren B, Haak A, van Burken G, Viergever MA, Bosch JG, Pluim JPW. Selection Strategies for Atlas-Based Mosaicing of Left Atrial 3-D Transesophageal Echocardiography Data. Ultrasound Med Biol. 2018 Jul;44(7):1533-1543.
  8. Ren B, Spitzer E, Geleijnse ML, Zijlstra F, de Jaegere PPT, Van Mieghem NM, Tijssen JG. Right ventricular systolic function in patients undergoing transcatheter aortic valve implantation: A systematic review and meta-analysis. Int J Cardiol. 2018 Apr 15;257:40-45.
  9. Spitzer E, Ren B, Zijlstra F, Mieghem NMV, Geleijnse ML. The Role of Automated 3D Echocardiography for Left Ventricular Ejection Fraction Assessment. Card Fail Rev. 2017 Nov;3(2):97-101.
  10. Erden M, van Velzen HG, Menting ME, van den Bosch AE, Ren B, Michels M, Vletter WB, van Domburg RT, Schinkel AFL. Three-dimensional echocardiography for the assessment of left ventricular geometry and papillary muscle morphology in hypertrophic cardiomyopathy. J Ultrasound. 2018 Mar;21(1):17-24.
  11. van Gils L, Clavel MA, Vollema EM, Hahn RT, Spitzer E, Delgado V, Nazif T, De Jaegere PP, Geleijnse ML, Ben-Yehuda O, Bax JJ, Leon MB, Pibarot P, Van Mieghem NM. Prognostic Implications of Moderate Aortic Stenosis in Patients With Left Ventricular Systolic Dysfunction. J Am Coll Cardiol. 2017 May 16;69(19):2383-2392.
  12. Spitzer E, Ren B, Soliman OI, Zijlstra F, Van Mieghem NM, Geleijnse ML. Accuracy of an automated transthoracic echocardiographic tool for 3D assessment of left heart chamber volumes. Echocardiography. 2017 Feb;34(2):199-209.
  13. Mulder HW, van Stralen M, Ren B, Haak A, Viergever MA, Bosch JG, Pluim JP. Atlas-Based Mosaicing of Left Atrial 3-D Transesophageal Echocardiography Images. Ultrasound Med Biol. 2017 Apr;43(4):765-774.
  14. Soliman OII, El Faquir N, Ren B, Spitzer E, van Gils L, Jonker H, Geleijnse ML, van Es GA, Tijssen JG, van Mieghem NM, de Jaegere PPT. Comparison of valve performance of the mechanically expanding Lotus and the balloon-expanded SAPIEN3 transcatheter heart valves: an observational study with independent core laboratory analysis. Eur Heart J Cardiovasc Imaging. 2018 Feb 1;19(2):157-167.
  15. Abdelghani M, Spitzer E, Ren B, Serruys PWJC, Soliman OII. Real-world feasibility of the VARC-recommended multiparametric approach for the assessment of post-TAVI aortic regurgitation. Int J Cardiol. 2016 Nov 15;223:220-221.
  16. Abdelghani M, Ren B, Spitzer E, Tateishi H, Jonker H, Geleijnse ML, Tijssen JG, de Winter RJ, Serruys PW, Soliman OI. A granular approach to improve reproducibility of the echocardiographic assessment of paravalvular regurgitation after TAVI. Int J Cardiovasc Imaging. 2016 Oct;32(10):1519-27.
  17. Abdelghani M, Tateishi H, Spitzer E, Tijssen JG, de Winter RJ, Soliman OI, Hahn RT, Serruys PW. Echocardiographic and angiographic assessment of paravalvular regurgitation after TAVI: optimizing inter-technique reproducibility. Eur Heart J Cardiovasc Imaging. 2016 Aug;17(8):852-60.
  18. de Groot-de Laat LE, Ren B, McGhie J, Oei FB, Strachinaru M, Kirschbaum SW, Akin S, Kievit CM, Bogers AJ, Geleijnse ML. The role of experience in echocardiographic identification of location and extent of mitral valve prolapse with 2D and 3D echocardiography. Int J Cardiovasc Imaging. 2016 Aug;32(8):1171-7.
  19. Spitzer E, Mercado J, Islas F, Rothenbühler M, Kurmann R, Zürcher F, Krähenmann P, Llerena N, Jüni P, Torres P, Pilgrim T. Screening for Rheumatic Heart Disease among Peruvian Children: A Two-Stage Sampling Observational Study. PLoS One. 2015 Jul 24;10(7):e0133004.
  20. Haak A, Vegas-Sánchez-Ferrero G, Mulder HW, Ren B, Kirişli HA, Metz C, van Burken G, van Stralen M, Pluim JP, van der Steen AF, van Walsum T, Bosch JG. Segmentation of multiple heart cavities in 3-D transesophageal ultrasound images. IEEE Trans Ultrason Ferroelectr Freq Control. 2015 Jun;62(6):1179-89.
  21. Haak A, Ren B, Mulder HW, Vegas-Sánchez-Ferrero G, van Burken G, van der Steen AF, van Stralen M, Pluim JP, van Walsum T, Bosch JG. Improved Segmentation of Multiple Cavities of the Heart in Wide-View 3-D Transesophageal Echocardiograms. Ultrasound Med Biol. 2015 Jul;41(7):1991-2000.
  22. De Groot-de Laat LE, Ren B, McGhie J, Oei FB, Raap GB, Bogers JJ, Geleijnse ML. Real-world echocardiography in patients referred for mitral valve surgery: the gap between guidelines and clinical practice. J Heart Valve Dis. 2014 Nov;23(6):721-6. PMID: 25790619.


Cardiac Computed Tomography

  1. Dedic A, ten Kate GJ, Rood PP, Galema TW, Ouhlous M, Moelker A, de Feyter PJ, de Rijke YB, Nieman K. Copeptin in acute chest pain: identification of acute coronary syndrome and obstructive coronary artery disease on coronary CT angiography. Emerg Med J. 2013 Nov;30(11):910-3.
  2. Dedic A, Ten Kate GJ, Neefjes LA, Rossi A, Dharampal A, Rood PP, Galema TW, Schultz C, Ouhlous M, Moelker A, de Feyter PJ, Nieman K. Coronary CT angiography outperforms calcium imaging in the triage of acute coronary syndrome. Int J Cardiol. 2013 Aug 20;167(4):1597-602.
  3. Dedic A, Genders TS, Ferket BS, Galema TW, Mollet NR, Moelker A, Hunink MG, de Feyter PJ, Nieman K. Stable angina pectoris: head-to-head comparison of prognostic value of cardiac CT and exercise testing. Radiology. 2011 Nov;261(2):428-36.
  4. Dedic A, Rossi A, Ten Kate GJ, Neefjes LA, Galema TW, Moelker A, van Domburg RT, Schultz CJ, Mollet NR, de Feyter PJ, Nieman K. First-line evaluation of coronary artery disease with coronary calcium scanning or exercise electrocardiography. Int J Cardiol. 2013 Feb 20;163(2):190-5.
  5. van den Hoven AT, Yilmazer S, Chelu RG, van Grootel RWJ, Minderhoud SCS, Bons LR, van Berendoncks AM, Duijnhouwer AL, Siebelink HJ, van den Bosch AE, Budde RPJ, Roos-Hesselink JW, Hirsch A. Left ventricular global longitudinal strain in bicupsid aortic valve patients: head-to-head comparison between computed tomography, 4D flow cardiovascular magnetic resonance and speckle-tracking echocardiography. Int J Cardiovasc Imaging. 2020 May 25.
  6. De Backer O, Dangas GD, Jilaihawi H, Leipsic JA, Terkelsen CJ, Makkar R, Kini AS, Veien KT, Abdel-Wahab M, Kim WK, Balan P, Van Mieghem N, Mathiassen ON, Jeger RV, Arnold M, Mehran R, Guimarães AHC, Nørgaard BL, Kofoed KF, Blanke P, Windecker S, Søndergaard L; GALILEO-4D Investigators. Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement. N Engl J Med. 2020 Jan 9;382(2):130-139.
  7. Alkema M, Spitzer E, Soliman OI, Loewe C. Multimodality Imaging for Left Ventricular Hypertrophy Severity Grading: A Methodological Review. J Cardiovasc Ultrasound. 2016 Dec;24(4):257-267.
  8. Abdelghani M, Spitzer E, Soliman OII, Beitzke D, Laggner R, Cavalcante R, Tateishi H, Campos CM, Verstraeten L, Sotomi Y, Tenekecioglu E, Onuma Y, Tijssen JG, de Winter RJ, Maisano F, Serruys PW. A simplified and reproducible method to size the mitral annulus: implications for transcatheter mitral valve replacement. Eur Heart J Cardiovasc Imaging. 2017 Jun 1;18(6):697-706.
  9. Van Mieghem NM, Rodríguez-Olivares R, Ren BC, van Gils L, Maugenest A, Geleijnse ML, Budde RP, Vogelaar J, Verstraeten L, de Jaegere PP. Computed tomography optimised fluoroscopy guidance for transcatheter mitral therapies. EuroIntervention. 2016 Mar;11(12):1428-31.
  10. Thériault-Lauzier P, Mylotte D, Dorfmeister M, Spaziano M, Andalib A, Mamane S, Chetrit M, Blanke P, Cecere R, Buithieu J, Martucci G, Tchetche D, Modine T, van Mieghem N, Lange R, Windecker S, Bilodeau L, Leipsic J, Piazza N. Quantitative multi-slice computed tomography assessment of the mitral valvular complex for transcatheter mitral valve interventions part 1: systematic measurement methodology and inter-observer variability. EuroIntervention. 2016 Oct 10;12(8):e1011-e1020.
  11. Gonçalves Pde A, Rodríguez-Granillo GA, Spitzer E, Suwannasom P, Loewe C, Nieman K, Garcia-Garcia HM. Functional Evaluation of Coronary Disease by CT Angiography. JACC Cardiovasc Imaging. 2015 Nov;8(11):1322-35.
  12. Tzikas A, Schultz CJ, Piazza N, Moelker A, Van Mieghem NM, Nuis RJ, van Geuns RJ, Geleijnse ML, Serruys PW, de Jaegere PP. Assessment of the aortic annulus by multislice computed tomography, contrast aortography, and trans-thoracic echocardiography in patients referred for transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2011 May 1;77(6):868-75.
  13. Tzikas A, Schultz C, Van Mieghem NM, de Jaegere PP, Serruys PW. Optimal projection estimation for transcatheter aortic valve implantation based on contrast-aortography: validation of a Prototype Software. Catheter Cardiovasc Interv. 2010 Oct 1;76(4):602-7.
  14. Arslan M, Schaap J, Rood PP, Nieman K, Budde RP, Attrach M, Dubois EA, Dedic A. HEART score improves efficiency of coronary computed tomography angiography in patients suspected of acute coronary syndrome in the emergency department. Eur Heart J Acute Cardiovasc Care. 2020 Feb;9(1):23-29.
  15. Dedic A, Lubbers MM, Schaap J, Lammers J, Lamfers EJ, Rensing BJ, Braam RL, Nathoe HM, Post JC, Nielen T, Beelen D, le Cocq d'Armandville MC, Rood PP, Schultz CJ, Moelker A, Ouhlous M, Boersma E, Nieman K. Coronary CT Angiography for Suspected ACS in the Era of High-Sensitivity Troponins: Randomized Multicenter Study. J Am Coll Cardiol. 2016 Jan 5;67(1):16-26.
  16. Dedic A, Ten Kate GJ, Roos CJ, Neefjes LA, de Graaf MA, Spronk A, Delgado V, van Lennep JE, Moelker A, Ouhlous M, Scholte AJ, Boersma E, Sijbrands EJ, Nieman K, Bax JJ, de Feijter PJ. Prognostic Value of Coronary Computed Tomography Imaging in Patients at High Risk Without Symptoms of Coronary Artery Disease. Am J Cardiol. 2016 Mar 1;117(5):768-74.
  17. Coenen A, Lubbers MM, Kurata A, Kono A, Dedic A, Chelu RG, Dijkshoorn ML, van Geuns RJ, Schoebinger M, Itu L, Sharma P, Nieman K. Coronary CT angiography derived fractional flow reserve: Methodology and evaluation of a point of care algorithm. J Cardiovasc Comput Tomogr. 2016 Mar-Apr;10(2):105-13.
  18. Coenen A, Lubbers MM, Kurata A, Kono A, Dedic A, Chelu RG, Dijkshoorn ML, Gijsen FJ, Ouhlous M, van Geuns RJ, Nieman K. Fractional flow reserve computed from noninvasive CT angiography data: diagnostic performance of an on-site clinician-operated computational fluid dynamics algorithm. Radiology. 2015 Mar;274(3):674-83.


Structural Heart 

  1. Van Mieghem NM, Popma JJ, Deeb GM, Yakubov SJ, Serruys PW, Windecker S, Søndergaard L, Mumtaz M, Gada H, Chetcuti S, Kleiman NS, Kodali S, George I, Teefy P, Kiaii B, Oh JK, Kappetein AP, Chang Y, Mugglin AS, Reardon MJ; SURTAVI Trial Investigators. Complete 2-Year Results Confirm Bayesian Analysis of the SURTAVI Trial. JACC Cardiovasc Interv. 2020 Feb 10;13(3):323-331.
  2. Strachinaru M, Ren B, van Dalen BM, Van Mieghem N, De Jaegere PPT, van Gils L, Galema TW, Geleijnse ML. Determinants of changes in pulmonary artery pressure in patients with severe aortic stenosis treated by transcatheter aortic valve implantation. Acta Cardiol. 2020 Jan 10:1-9.
  3. Spitzer E, Hahn RT, Pibarot P, de Vries T, Bax JJ, Leon MB, Van Mieghem NM. Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials. Card Fail Rev. 2019 May 24;5(2):99-105.
  4. Van Mieghem NM, Wöhrle J, Hildick-Smith D, Bleiziffer S, Blackman DJ, Abdel-Wahab M, Gerckens U, Linke A, Ince H, Wenaweser P, Allocco DJ, Meredith IT, Falk V. Use of a Repositionable and Fully Retrievable Aortic Valve in Routine Clinical Practice: The RESPOND Study and RESPOND Extension Cohort. JACC Cardiovasc Interv. 2019 Jan 14;12(1):38-49.
  5. Spitzer E, Ren B, Kroon H, van Gils L, Manintveld O, Daemen J, Zijlstra F, de Jaegere PP, Geleijnse ML, Van Mieghem NM. Moderate Aortic Stenosis and Reduced Left Ventricular Ejection Fraction: Current Evidence and Challenges Ahead. Front Cardiovasc Med. 2018 Aug 17;5:111.
  6. Van Mieghem NM, Unverdorben M, Valgimigli M, Mehran R, Boersma E, Baber U, Hengstenberg C, Shi M, Chen C, Saito S, Veltkamp R, Vranckx P, Dangas GD. Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation-Rationale and design of the ENVISAGE-TAVI AF trial. Am Heart J. 2018 Nov;205:63-69.
  7. Ren B, Spitzer E, Geleijnse ML, Zijlstra F, de Jaegere PPT, Van Mieghem NM, Tijssen JG. Right ventricular systolic function in patients undergoing transcatheter aortic valve implantation: A systematic review and meta-analysis. Int J Cardiol. 2018 Apr 15;257:40-45.
  8. El Faquir N, Ren B, Faure M, de Ronde M, Geeve P, Maugenest AM, Kardys I, Geleijnse ML, de Jaegere PP, Budde RPJ, Van Mieghem NM. Long-Term Structural Integrity and Durability of the Medtronic CoreValve System After Transcatheter Aortic Valve Replacement. JACC Cardiovasc Imaging. 2018 May;11(5):781-783.
  9. Van Mieghem NM, Latib A, van der Heyden J, van Gils L, Daemen J, Sorzano T, Ligthart J, Witberg K, de Kroon T, Maor N, Mangieri A, Montorfano M, de Jaegere PP, Colombo A, Roubin G. Percutaneous Plug-Based Arteriotomy Closure Device for Large-Bore Access: A Multicenter Prospective Study. JACC Cardiovasc Interv. 2017 Mar 27;10(6):613-619.
  10. Soliman OII, El Faquir N, Ren B, Spitzer E, van Gils L, Jonker H, Geleijnse ML, van Es GA, Tijssen JG, van Mieghem NM, de Jaegere PPT. Comparison of valve performance of the mechanically expanding Lotus and the balloon-expanded SAPIEN3 transcatheter heart valves: an observational study with independent core laboratory analysis. Eur Heart J Cardiovasc Imaging. 2018 Feb 1;19(2):157-167.
  11. Ren B, Rahhab Z, von der Thüsen J, Daemen J, Geleijnse ML, de Jaegere PP, Kappetein AP, Van Mieghem NM. Transcatheter Lotus Valve Implantation in a Stenotic Mitral Valve. JACC Cardiovasc Interv. 2016 Nov 14;9(21):e215-e217.
  12. Van Mieghem NM, van Gils L, Ahmad H, van Kesteren F, van der Werf HW, Brueren G, Storm M, Lenzen M, Daemen J, van den Heuvel AF, Tonino P, Baan J, Koudstaal PJ, Schipper ME, van der Lugt A, de Jaegere PP. Filter-based cerebral embolic protection with transcatheter aortic valve implantation: the randomized MISTRAL-C trial. EuroIntervention. 2016 Jul 20;12(4):499-507.
  13. Van Mieghem NM, Rodríguez-Olivares R, Ren BC, van Gils L, Maugenest A, Geleijnse ML, Budde RP, Vogelaar J, Verstraeten L, de Jaegere PP. Computed tomography optimised fluoroscopy guidance for transcatheter mitral therapies. EuroIntervention. 2016 Mar;11(12):1428-31.
  14. Van Mieghem NM, Généreux P, van der Boon RM, Kodali S, Head S, Williams M, Daneault B, Kappetein AP, de Jaegere PP, Leon MB, Serruys PW. Transcatheter aortic valve replacement and vascular complications definitions. EuroIntervention. 2014 Mar 20;9(11):1317-22.
  15. Van Mieghem NM, Piazza N, Anderson RH, Tzikas A, Nieman K, De Laat LE, McGhie JS, Geleijnse ML, Feldman T, Serruys PW, de Jaegere PP. Anatomy of the mitral valvular complex and its implications for transcatheter interventions for mitral regurgitation. J Am Coll Cardiol. 2010 Aug 17;56(8):617-26.


Renal Denervation

  1. Daemen J, Mahfoud F, Kuck KH, Andersson B, Böhm M, Graf T, Sievert H, Kahlert P, Iyer M, Zeller T. Safety and efficacy of endovascular ultrasound renal denervation in resistant hypertension: 12-month results from the ACHIEVE study. J Hypertens. 2019 Sep;37(9):1906-1912.
  2. Azizi M, Schmieder RE, Mahfoud F, Weber MA, Daemen J, Lobo MD, Sharp ASP, Bloch MJ, Basile J, Wang Y, Saxena M, Lurz P, Rader F, Sayer J, Fisher NDL, Fouassier D, Barman NC, Reeve-Stoffer H, McClure C, Kirtane AJ; RADIANCE-HTN Investigators. Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control Following Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial. Circulation. 2019 Mar 17.
  3. Feyz L, Theuns DA, Bhagwandien R, Strachinaru M, Kardys I, Van Mieghem NM, Daemen J. Atrial fibrillation reduction by renal sympathetic denervation: 12 months' results of the AFFORD study. Clin Res Cardiol. 2019 Jun;108(6):634-642. doi: 10.1007/s00392-018-1391-3.
  4. Tsioufis KP, Feyz L, Dimitriadis K, Konstantinidis D, Tousoulis D, Voskuil M, Mahfoud F, Daemen J. Safety and performance of diagnostic electrical mapping of renal nerves in hypertensive patients. 2018 Dec 20;14(12):e1334-e1342.
  5. Mauri L, Kario K, Basile J, Daemen J, Davies J, Kirtane AJ, Mahfoud F, Schmieder RE, Weber M, Nanto S, Azizi M. A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs. Am Heart J. 2018 Jan;195:115-129.
  6. Feyz L, van Dalen BM, Geleijnse ML, Van Mieghem NM, van Domburg RT, Daemen J. Effect of catheter-based renal denervation on left ventricular function, mass and (un)twist with two-dimensional speckle tracking echocardiography. J Echocardiogr. 2017 Dec;15(4):158-165.
  7. van Zandvoort L, van Kranenburg M, Karanasos A, Van Mieghem N, Ouhlous M, van Geuns RJ, van Domburg R, Daemen J. Serial quantitative magnetic resonance angiography follow-up of renal artery dimensions following treatment by four different renal denervation systems. EuroIntervention. 2017 Apr 7;12(18):e2271-e2277.
  8. van Kranenburg M, Karanasos A, Chelu RG, van der Heide E, Ouhlous M, Nieman K, van Mieghem N, Krestin G, Niessen W, Zijlstra F, van Geuns RJ, Daemen J. Validation of renal artery dimensions measured by magnetic resonance angiography in patients referred for renal sympathetic denervation. Acad Radiol. 2015 Sep;22(9):1106-14.
  9. Karanasos A, Van Mieghem N, Bergmann MW, Hartman E, Ligthart J, van der Heide E, Heeger CH, Ouhlous M, Zijlstra F, Regar E, Daemen J. Multimodality Intra-Arterial Imaging Assessment of the Vascular Trauma Induced by Balloon- Based and Nonballoon-Based Renal Denervation Systems. Circ Cardiovasc Interv. 2015 Jul;8(7):e002474.
  10. Karanasos A, Van Mieghem NM, Regar E, Daemen J. Serial imaging observations of vascular healing in a denervation-induced renal artery dissection. Eur Heart J. 2015 May 1;36(17):1040.